AMH is a hormone used as part of the assessment of ovarian reserve, indicating the anticipated number of follicles likely to respond to a stimulation cycle. A low reading may suggest that a more detailed discussion is warranted, particularly when planning assisted reproductive therapy.

Crucially, it does not imply that a woman is unable to conceive. It is not a direct measure of egg quality, nor does it independently predict the natural likelihood of conception in any given month. It simply cannot be interpreted in isolation; it must be assessed alongside age, ultrasound findings, medical history, menstrual cycle patterns and any previous treatment cycles.

The value of AMH is highly practical: it helps to guide further investigation or, where appropriate, to design a tailored treatment strategy. Rather than asking 'is my AMH good or bad?', a more helpful question is 'what does this value mean for my personal fertility journey?'.

A common question we hear is: 'Should I repeat the AMH test on a regular basis?' Not necessarily. The benefit of repeating the test depends entirely on the clinical context and your overall treatment plan.

In summary: a test result is simply data. It is the medical interpretation that translates that data into an informed choice.